Dr. Rogers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
- Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2009
- Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2004
- Harvard Medical SchoolClass of 2001
Certifications & Licensure
- CA State Medical License 2013 - 2027
- MA State Medical License 2004 - 2015
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START) Start of enrollment: 2014 Mar 15
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol Start of enrollment: 2021 Apr 23
Publications & Presentations
PubMed
- SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial).Sofía Sábato, Susana Benet, Angela J Rogers, Thomas A Murray, Melissa Skeans
Scientific Reports. 2025-03-22 - Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019.Cavan Reilly, Eleftherios Mylonakis, Robin Dewar, Barnaby Young, Jacqueline Nordwall
The Journal of Infectious Diseases. 2025-03-17 - Prior vaccination prevents overactivation of innate immune responses during COVID-19 breakthrough infection.Leslie Chan, Kassandra Pinedo, Mikayla A Stabile, Rebecca E Hamlin, Shaun M Pienkos
Science Translational Medicine. 2025-01-29
Press Mentions
- Test Predicts Which COVID-19 Patients Will Grow Worse, Stanford Medicine Study FindSeptember 26th, 2022
- The Proof Is in the Plasma: SARS-CoV-2 Antigen Levels Predict SeverityAugust 30th, 2022
- Scientists Decipher the Danger of Gummy Phlegm in Severe COVID-19June 24th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: